This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of ledipasvir and sofosbuvir: A Synthesis of Findings from 7 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of ledipasvir and sofosbuvir: A Synthesis of Findings from 7 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to Dataset
Please check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

The use of L-T4 (levothyroxine) in the treatment of primary hypothyroidism can cause oxidative stress (OS) and daily discomfort. 4 A study on the effect of short-term metformin therapy associated with levothyroxine dose decrement on TSH and thyroid hormone levels in patients with differentiated thyroid cancer (DTC) was conducted. 5 The results of a randomized, double-blind, crossover trial of liothyronine versus levothyroxine demonstrated that levothyroxine therapy is based on the assumption that the conversion of T(4) into T(3) provides adequate amounts of active hormone at target tissues. 3 Another randomized double-blind crossover trial investigated the effects of evening vs morning levothyroxine intake. 2 A study compared the effects of thyroxine alone with those of thyroxine plus triiodothyronine (liothyronine) in 33 patients with hypothyroidism. 1 The effects of levothyroxine for subclinical hypothyroidism (SHypo) on bone health in older adults were assessed in a randomized trial. 6

Benefits and Risks

Benefit Summary

Some physiological modulators (PMs) may make the treatment of primary hypothyroidism more tolerable. 4 The use of a formula containing OPA with other PMs may limit the incidence of the side effects that occur during the initial phase of L-T4 treatment in hypothyroidism. 4 In patients with hypothyroidism, partial substitution of triiodothyronine for thyroxine may improve mood and neuropsychological function. 1

Risk Summary

Adding 500 mg of metformin to the drug regimen was not useful to compensate for 33% of levothyroxine dose reduction in patients with DTC. 5 Over 1-year levothyroxine had no effect on bone health in older adults with SHypo. 6

Comparison Between Studies

Similarities Between Studies

Multiple studies have investigated the effects of levothyroxine and other treatments for hypothyroidism. 4 , 5 , 3 , 2 , 1 , 6 These studies have explored various aspects of hypothyroidism treatment, including the effects of levothyroxine, alternative therapies, and potential side effects. They have utilized different methodologies, such as randomized controlled trials and crossover studies, to investigate the effectiveness and safety of various treatment approaches.

Differences Between Studies

Multiple studies have investigated the effects of levothyroxine and other treatments for hypothyroidism. 4 , 5 , 3 , 2 , 1 , 6 While these studies have provided valuable insights into hypothyroidism treatment, there are some differences between them, such as the specific treatments investigated, the study populations, and the duration of follow-up. The variations in these aspects may contribute to the variability in results and interpretations.

Consistency and Inconsistencies of Results

Multiple studies have investigated the effects of levothyroxine and other treatments for hypothyroidism. 4 , 5 , 3 , 2 , 1 , 6 While these studies have provided valuable insights into hypothyroidism treatment, there are some differences between them, such as the specific treatments investigated, the study populations, and the duration of follow-up. The variations in these aspects may contribute to the variability in results and interpretations. It is important to acknowledge that the results of these studies may not be generalizable to all individuals with hypothyroidism.

Important Considerations for Real-World Applications

Hypothyroidism is a common endocrine disorder that requires careful management. 7 The treatment of hypothyroidism often involves the use of levothyroxine, but there are potential side effects and complexities associated with this medication. If you are diagnosed with hypothyroidism, it is essential to consult with your healthcare provider to discuss your treatment options and develop a personalized management plan that addresses your individual needs and concerns. Regular monitoring of thyroid hormone levels and a close collaboration with your doctor are crucial for optimizing treatment and ensuring the best possible outcomes.

Limitations of Current Research

While research on hypothyroidism treatment is ongoing, there are limitations to the existing studies. 4 , 5 , 3 , 2 , 1 , 6 These studies may have limited sample sizes, specific populations studied, or follow-up durations. Further research is needed to investigate the long-term effects of various treatments, the effectiveness in diverse populations, and the optimal management strategies for different subtypes of hypothyroidism.

Future Research Directions

More research is needed to fully understand the complexities of hypothyroidism and its management. 7 Future studies should focus on exploring the long-term effects of levothyroxine and alternative treatments, evaluating the effectiveness in diverse patient populations, and investigating the potential benefits and risks of various treatment approaches. Additionally, research on the interplay between hypothyroidism and other health conditions is essential for optimizing patient care.

Conclusion

Hypothyroidism is a common endocrine disorder that requires careful management. 7 While levothyroxine remains the primary treatment, ongoing research is exploring alternative approaches and addressing potential side effects. If you are diagnosed with hypothyroidism, it is essential to consult with your healthcare provider to develop a personalized treatment plan that aligns with your specific needs and concerns. Regular monitoring and a close collaboration with your doctor are crucial for ensuring the best possible outcomes.


Literature analysis of 7 papers
Positive Content
5
Neutral Content
1
Negative Content
1
Article Type
6
0
1
0
7

Language : English


Language : English


Language : English


Language : English


Language : English


Author: Gonzalez RodriguezElena, StuberMirah, Del GiovaneCinzia, FellerMartin, ColletTinh-Hai, LöweAxel L, BlumManuel R, van VlietNicolien A, van HeemstDiana, KearneyPatricia M, GusseklooJacobijn, MooijaartSimon, WestendorpRudi G J, StottDavid J, AeberliDaniel, BauerDouglas C, HansDidier, RodondiNicolas


Language : English


Language : English


This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.